New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma
We classified hydronephrosis based on renal excretion of FDG on FDG-PET/CT. The classification predicted post-operative renal function and pathological outcomes in patients with upper urinary tract urothelial carcinoma. Abstract Objectives To evaluate the value of a classification of hydronephrosis...
Gespeichert in:
| Veröffentlicht in: | Japanese journal of clinical oncology 2018-11, Vol.48 (11), p.1022-1027 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1027 |
|---|---|
| container_issue | 11 |
| container_start_page | 1022 |
| container_title | Japanese journal of clinical oncology |
| container_volume | 48 |
| creator | Asai, Seiji Fukumoto, Tetsuya Watanabe, Ryuta Koyama, Kanae Sawada, Yuichiro Noda, Terutaka Miura, Noriyoshi Yanagihara, Yutaka Miyauchi, Yuki Miyagawa, Masao Kikugawa, Tadahiko Saika, Takashi |
| description | We classified hydronephrosis based on renal excretion of FDG on FDG-PET/CT. The classification predicted post-operative renal function and pathological outcomes in patients with upper urinary tract urothelial carcinoma.
Abstract
Objectives
To evaluate the value of a classification of hydronephrosis on 18F-flurodeoxyglucose (FDG)-PET/CT in predicting post-operative renal function and pathological outcomes among patients with upper urinary tract urothelial carcinoma.
Methods
We retrospectively reviewed 71 patients treated with nephroureterectomy (NU) for upper urinary tract urothelial carcinoma after FDG-PET/CT between 2010 and 2016. Eight patients treated with ureteral stent or nephrostomy at the time of FDG-PET/CT were excluded. We classified hydronephrosis based on renal excretion of FDG as follows: Type 0, no hydronephrosis; Type 1, hydronephrosis with FDG excretion; and Type 2, hydronephrosis without FDG excretion. eGFR was recorded before pre-operataive FDG-PET/CT examination and after nephroureterectomy.
Results
Thirty-three patients (52%) had hydronephrosis, classified as Type 1 in 19 patients (30%) and Type 2 in 14 (22%). Type 2 hydronephrosis was associated with ureteral cancer and severe hydronephrosis on CT. Median changes in eGFR before and after nephroureterectomy in patients classified as Type 0, 1 and 2 were −23.9, −18.8 and 2.0 ml/min/1.73 m2, respectively. On multivariate analysis, Type 2 hydronephrosis was a significant predictor of change in eGFR (P = 0.001). Rates of muscle-invasive upper urinary tract urothelial carcinoma among Type 0, 1 and 2 patients were 37, 42 and 86%, respectively. On multivariate analysis, Type 2 hydronephrosis was a significant predictor of muscle-invasive upper urinary tract urothelial carcinoma (P = 0.032, OR 6.491).
Conclusions
This classification of hydronephrosis from FDG-PET/CT is simple and useful for predicting post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma, especially with ureteral cancer. This classification can help in deciding eligibility for lymphadenectomy or perioperative cisplatin-based chemotherapy. |
| doi_str_mv | 10.1093/jjco/hyy135 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2112190386</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jjco/hyy135</oup_id><sourcerecordid>2112190386</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2265-a8f08d951a45aec5103c9559cfea23d50f41c71bc97f95f2a368a9c66a9db1933</originalsourceid><addsrcrecordid>eNp9kc1uEzEUhS0EoqWwYo-8QkhoiH_iyXiJ0qZUqloWYT268VxrHM3Yxp5plefiBXFIQay68o---0nnHkLec_aFMy0X-70Ji_5w4FK9IOd8WatK1oK__O9-Rt7kvGeMqWa5ek3OJBNKcCbPya87fKRmgJyddQYmFzwNlvaHLgWPsU8hu0zLJ2821ebyuvp-tV2stzQm7JyZMo0hT1WImMrsA9KEHgZqZ2_-qMB3dJyzGbBy_gHyEelcRshInaexDKEvlkc39XSORUPn5DykA50SmKm8wtTj4IrUQDLOhxHeklcWhozvns4L8mNztV1_q27vr2_WX28rI0QJDo1lTacVh6UCNKrkNVopbSyCkJ1idsnNiu-MXlmtrABZN6BNXYPudlxLeUE-nbwxhZ8z5qkdXTY4DOAxzLkVnAuumWzqgn4-oaYsLCe0bUxuLDFaztpjS-2xpfbUUqE_PInn3YjdP_ZvLQX4eALCHJ81_QYtPaAD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2112190386</pqid></control><display><type>article</type><title>New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Asai, Seiji ; Fukumoto, Tetsuya ; Watanabe, Ryuta ; Koyama, Kanae ; Sawada, Yuichiro ; Noda, Terutaka ; Miura, Noriyoshi ; Yanagihara, Yutaka ; Miyauchi, Yuki ; Miyagawa, Masao ; Kikugawa, Tadahiko ; Saika, Takashi</creator><creatorcontrib>Asai, Seiji ; Fukumoto, Tetsuya ; Watanabe, Ryuta ; Koyama, Kanae ; Sawada, Yuichiro ; Noda, Terutaka ; Miura, Noriyoshi ; Yanagihara, Yutaka ; Miyauchi, Yuki ; Miyagawa, Masao ; Kikugawa, Tadahiko ; Saika, Takashi</creatorcontrib><description>We classified hydronephrosis based on renal excretion of FDG on FDG-PET/CT. The classification predicted post-operative renal function and pathological outcomes in patients with upper urinary tract urothelial carcinoma.
Abstract
Objectives
To evaluate the value of a classification of hydronephrosis on 18F-flurodeoxyglucose (FDG)-PET/CT in predicting post-operative renal function and pathological outcomes among patients with upper urinary tract urothelial carcinoma.
Methods
We retrospectively reviewed 71 patients treated with nephroureterectomy (NU) for upper urinary tract urothelial carcinoma after FDG-PET/CT between 2010 and 2016. Eight patients treated with ureteral stent or nephrostomy at the time of FDG-PET/CT were excluded. We classified hydronephrosis based on renal excretion of FDG as follows: Type 0, no hydronephrosis; Type 1, hydronephrosis with FDG excretion; and Type 2, hydronephrosis without FDG excretion. eGFR was recorded before pre-operataive FDG-PET/CT examination and after nephroureterectomy.
Results
Thirty-three patients (52%) had hydronephrosis, classified as Type 1 in 19 patients (30%) and Type 2 in 14 (22%). Type 2 hydronephrosis was associated with ureteral cancer and severe hydronephrosis on CT. Median changes in eGFR before and after nephroureterectomy in patients classified as Type 0, 1 and 2 were −23.9, −18.8 and 2.0 ml/min/1.73 m2, respectively. On multivariate analysis, Type 2 hydronephrosis was a significant predictor of change in eGFR (P = 0.001). Rates of muscle-invasive upper urinary tract urothelial carcinoma among Type 0, 1 and 2 patients were 37, 42 and 86%, respectively. On multivariate analysis, Type 2 hydronephrosis was a significant predictor of muscle-invasive upper urinary tract urothelial carcinoma (P = 0.032, OR 6.491).
Conclusions
This classification of hydronephrosis from FDG-PET/CT is simple and useful for predicting post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma, especially with ureteral cancer. This classification can help in deciding eligibility for lymphadenectomy or perioperative cisplatin-based chemotherapy.</description><identifier>ISSN: 1465-3621</identifier><identifier>EISSN: 1465-3621</identifier><identifier>DOI: 10.1093/jjco/hyy135</identifier><identifier>PMID: 30252103</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Aged ; Aged, 80 and over ; Cisplatin - administration & dosage ; Female ; Fluorodeoxyglucose F18 - chemistry ; Glomerular Filtration Rate ; Humans ; Hydronephrosis - classification ; Hydronephrosis - complications ; Hydronephrosis - diagnostic imaging ; Hydronephrosis - surgery ; Kidney - physiopathology ; Male ; Middle Aged ; Multivariate Analysis ; Nephrectomy ; Nephroureterectomy ; Positron Emission Tomography Computed Tomography ; Postoperative Period ; Retrospective Studies ; Treatment Outcome ; Ureter - surgery ; Urologic Neoplasms - diagnostic imaging ; Urologic Neoplasms - physiopathology ; Urologic Neoplasms - surgery ; Urothelium - diagnostic imaging ; Urothelium - pathology ; Urothelium - surgery</subject><ispartof>Japanese journal of clinical oncology, 2018-11, Vol.48 (11), p.1022-1027</ispartof><rights>The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2265-a8f08d951a45aec5103c9559cfea23d50f41c71bc97f95f2a368a9c66a9db1933</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30252103$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asai, Seiji</creatorcontrib><creatorcontrib>Fukumoto, Tetsuya</creatorcontrib><creatorcontrib>Watanabe, Ryuta</creatorcontrib><creatorcontrib>Koyama, Kanae</creatorcontrib><creatorcontrib>Sawada, Yuichiro</creatorcontrib><creatorcontrib>Noda, Terutaka</creatorcontrib><creatorcontrib>Miura, Noriyoshi</creatorcontrib><creatorcontrib>Yanagihara, Yutaka</creatorcontrib><creatorcontrib>Miyauchi, Yuki</creatorcontrib><creatorcontrib>Miyagawa, Masao</creatorcontrib><creatorcontrib>Kikugawa, Tadahiko</creatorcontrib><creatorcontrib>Saika, Takashi</creatorcontrib><title>New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma</title><title>Japanese journal of clinical oncology</title><addtitle>Jpn J Clin Oncol</addtitle><description>We classified hydronephrosis based on renal excretion of FDG on FDG-PET/CT. The classification predicted post-operative renal function and pathological outcomes in patients with upper urinary tract urothelial carcinoma.
Abstract
Objectives
To evaluate the value of a classification of hydronephrosis on 18F-flurodeoxyglucose (FDG)-PET/CT in predicting post-operative renal function and pathological outcomes among patients with upper urinary tract urothelial carcinoma.
Methods
We retrospectively reviewed 71 patients treated with nephroureterectomy (NU) for upper urinary tract urothelial carcinoma after FDG-PET/CT between 2010 and 2016. Eight patients treated with ureteral stent or nephrostomy at the time of FDG-PET/CT were excluded. We classified hydronephrosis based on renal excretion of FDG as follows: Type 0, no hydronephrosis; Type 1, hydronephrosis with FDG excretion; and Type 2, hydronephrosis without FDG excretion. eGFR was recorded before pre-operataive FDG-PET/CT examination and after nephroureterectomy.
Results
Thirty-three patients (52%) had hydronephrosis, classified as Type 1 in 19 patients (30%) and Type 2 in 14 (22%). Type 2 hydronephrosis was associated with ureteral cancer and severe hydronephrosis on CT. Median changes in eGFR before and after nephroureterectomy in patients classified as Type 0, 1 and 2 were −23.9, −18.8 and 2.0 ml/min/1.73 m2, respectively. On multivariate analysis, Type 2 hydronephrosis was a significant predictor of change in eGFR (P = 0.001). Rates of muscle-invasive upper urinary tract urothelial carcinoma among Type 0, 1 and 2 patients were 37, 42 and 86%, respectively. On multivariate analysis, Type 2 hydronephrosis was a significant predictor of muscle-invasive upper urinary tract urothelial carcinoma (P = 0.032, OR 6.491).
Conclusions
This classification of hydronephrosis from FDG-PET/CT is simple and useful for predicting post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma, especially with ureteral cancer. This classification can help in deciding eligibility for lymphadenectomy or perioperative cisplatin-based chemotherapy.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cisplatin - administration & dosage</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18 - chemistry</subject><subject>Glomerular Filtration Rate</subject><subject>Humans</subject><subject>Hydronephrosis - classification</subject><subject>Hydronephrosis - complications</subject><subject>Hydronephrosis - diagnostic imaging</subject><subject>Hydronephrosis - surgery</subject><subject>Kidney - physiopathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Nephrectomy</subject><subject>Nephroureterectomy</subject><subject>Positron Emission Tomography Computed Tomography</subject><subject>Postoperative Period</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Ureter - surgery</subject><subject>Urologic Neoplasms - diagnostic imaging</subject><subject>Urologic Neoplasms - physiopathology</subject><subject>Urologic Neoplasms - surgery</subject><subject>Urothelium - diagnostic imaging</subject><subject>Urothelium - pathology</subject><subject>Urothelium - surgery</subject><issn>1465-3621</issn><issn>1465-3621</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1uEzEUhS0EoqWwYo-8QkhoiH_iyXiJ0qZUqloWYT268VxrHM3Yxp5plefiBXFIQay68o---0nnHkLec_aFMy0X-70Ji_5w4FK9IOd8WatK1oK__O9-Rt7kvGeMqWa5ek3OJBNKcCbPya87fKRmgJyddQYmFzwNlvaHLgWPsU8hu0zLJ2821ebyuvp-tV2stzQm7JyZMo0hT1WImMrsA9KEHgZqZ2_-qMB3dJyzGbBy_gHyEelcRshInaexDKEvlkc39XSORUPn5DykA50SmKm8wtTj4IrUQDLOhxHeklcWhozvns4L8mNztV1_q27vr2_WX28rI0QJDo1lTacVh6UCNKrkNVopbSyCkJ1idsnNiu-MXlmtrABZN6BNXYPudlxLeUE-nbwxhZ8z5qkdXTY4DOAxzLkVnAuumWzqgn4-oaYsLCe0bUxuLDFaztpjS-2xpfbUUqE_PInn3YjdP_ZvLQX4eALCHJ81_QYtPaAD</recordid><startdate>20181101</startdate><enddate>20181101</enddate><creator>Asai, Seiji</creator><creator>Fukumoto, Tetsuya</creator><creator>Watanabe, Ryuta</creator><creator>Koyama, Kanae</creator><creator>Sawada, Yuichiro</creator><creator>Noda, Terutaka</creator><creator>Miura, Noriyoshi</creator><creator>Yanagihara, Yutaka</creator><creator>Miyauchi, Yuki</creator><creator>Miyagawa, Masao</creator><creator>Kikugawa, Tadahiko</creator><creator>Saika, Takashi</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20181101</creationdate><title>New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma</title><author>Asai, Seiji ; Fukumoto, Tetsuya ; Watanabe, Ryuta ; Koyama, Kanae ; Sawada, Yuichiro ; Noda, Terutaka ; Miura, Noriyoshi ; Yanagihara, Yutaka ; Miyauchi, Yuki ; Miyagawa, Masao ; Kikugawa, Tadahiko ; Saika, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2265-a8f08d951a45aec5103c9559cfea23d50f41c71bc97f95f2a368a9c66a9db1933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cisplatin - administration & dosage</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18 - chemistry</topic><topic>Glomerular Filtration Rate</topic><topic>Humans</topic><topic>Hydronephrosis - classification</topic><topic>Hydronephrosis - complications</topic><topic>Hydronephrosis - diagnostic imaging</topic><topic>Hydronephrosis - surgery</topic><topic>Kidney - physiopathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Nephrectomy</topic><topic>Nephroureterectomy</topic><topic>Positron Emission Tomography Computed Tomography</topic><topic>Postoperative Period</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Ureter - surgery</topic><topic>Urologic Neoplasms - diagnostic imaging</topic><topic>Urologic Neoplasms - physiopathology</topic><topic>Urologic Neoplasms - surgery</topic><topic>Urothelium - diagnostic imaging</topic><topic>Urothelium - pathology</topic><topic>Urothelium - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asai, Seiji</creatorcontrib><creatorcontrib>Fukumoto, Tetsuya</creatorcontrib><creatorcontrib>Watanabe, Ryuta</creatorcontrib><creatorcontrib>Koyama, Kanae</creatorcontrib><creatorcontrib>Sawada, Yuichiro</creatorcontrib><creatorcontrib>Noda, Terutaka</creatorcontrib><creatorcontrib>Miura, Noriyoshi</creatorcontrib><creatorcontrib>Yanagihara, Yutaka</creatorcontrib><creatorcontrib>Miyauchi, Yuki</creatorcontrib><creatorcontrib>Miyagawa, Masao</creatorcontrib><creatorcontrib>Kikugawa, Tadahiko</creatorcontrib><creatorcontrib>Saika, Takashi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asai, Seiji</au><au>Fukumoto, Tetsuya</au><au>Watanabe, Ryuta</au><au>Koyama, Kanae</au><au>Sawada, Yuichiro</au><au>Noda, Terutaka</au><au>Miura, Noriyoshi</au><au>Yanagihara, Yutaka</au><au>Miyauchi, Yuki</au><au>Miyagawa, Masao</au><au>Kikugawa, Tadahiko</au><au>Saika, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma</atitle><jtitle>Japanese journal of clinical oncology</jtitle><addtitle>Jpn J Clin Oncol</addtitle><date>2018-11-01</date><risdate>2018</risdate><volume>48</volume><issue>11</issue><spage>1022</spage><epage>1027</epage><pages>1022-1027</pages><issn>1465-3621</issn><eissn>1465-3621</eissn><abstract>We classified hydronephrosis based on renal excretion of FDG on FDG-PET/CT. The classification predicted post-operative renal function and pathological outcomes in patients with upper urinary tract urothelial carcinoma.
Abstract
Objectives
To evaluate the value of a classification of hydronephrosis on 18F-flurodeoxyglucose (FDG)-PET/CT in predicting post-operative renal function and pathological outcomes among patients with upper urinary tract urothelial carcinoma.
Methods
We retrospectively reviewed 71 patients treated with nephroureterectomy (NU) for upper urinary tract urothelial carcinoma after FDG-PET/CT between 2010 and 2016. Eight patients treated with ureteral stent or nephrostomy at the time of FDG-PET/CT were excluded. We classified hydronephrosis based on renal excretion of FDG as follows: Type 0, no hydronephrosis; Type 1, hydronephrosis with FDG excretion; and Type 2, hydronephrosis without FDG excretion. eGFR was recorded before pre-operataive FDG-PET/CT examination and after nephroureterectomy.
Results
Thirty-three patients (52%) had hydronephrosis, classified as Type 1 in 19 patients (30%) and Type 2 in 14 (22%). Type 2 hydronephrosis was associated with ureteral cancer and severe hydronephrosis on CT. Median changes in eGFR before and after nephroureterectomy in patients classified as Type 0, 1 and 2 were −23.9, −18.8 and 2.0 ml/min/1.73 m2, respectively. On multivariate analysis, Type 2 hydronephrosis was a significant predictor of change in eGFR (P = 0.001). Rates of muscle-invasive upper urinary tract urothelial carcinoma among Type 0, 1 and 2 patients were 37, 42 and 86%, respectively. On multivariate analysis, Type 2 hydronephrosis was a significant predictor of muscle-invasive upper urinary tract urothelial carcinoma (P = 0.032, OR 6.491).
Conclusions
This classification of hydronephrosis from FDG-PET/CT is simple and useful for predicting post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma, especially with ureteral cancer. This classification can help in deciding eligibility for lymphadenectomy or perioperative cisplatin-based chemotherapy.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>30252103</pmid><doi>10.1093/jjco/hyy135</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1465-3621 |
| ispartof | Japanese journal of clinical oncology, 2018-11, Vol.48 (11), p.1022-1027 |
| issn | 1465-3621 1465-3621 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2112190386 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Aged Aged, 80 and over Cisplatin - administration & dosage Female Fluorodeoxyglucose F18 - chemistry Glomerular Filtration Rate Humans Hydronephrosis - classification Hydronephrosis - complications Hydronephrosis - diagnostic imaging Hydronephrosis - surgery Kidney - physiopathology Male Middle Aged Multivariate Analysis Nephrectomy Nephroureterectomy Positron Emission Tomography Computed Tomography Postoperative Period Retrospective Studies Treatment Outcome Ureter - surgery Urologic Neoplasms - diagnostic imaging Urologic Neoplasms - physiopathology Urologic Neoplasms - surgery Urothelium - diagnostic imaging Urothelium - pathology Urothelium - surgery |
| title | New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A44%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20classification%20of%20hydronephrosis%20on%2018F-FDG-PET/CT%20predicts%20post-operative%20renal%20function%20and%20muscle-invasive%20disease%20in%20patients%20with%20upper%20urinary%20tract%20urothelial%20carcinoma&rft.jtitle=Japanese%20journal%20of%20clinical%20oncology&rft.au=Asai,%20Seiji&rft.date=2018-11-01&rft.volume=48&rft.issue=11&rft.spage=1022&rft.epage=1027&rft.pages=1022-1027&rft.issn=1465-3621&rft.eissn=1465-3621&rft_id=info:doi/10.1093/jjco/hyy135&rft_dat=%3Cproquest_cross%3E2112190386%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2112190386&rft_id=info:pmid/30252103&rft_oup_id=10.1093/jjco/hyy135&rfr_iscdi=true |